Fetal hypoxia is assessed by?

HPSSC - 2015

Obstetrics and Midwifery Nursing

Medium

Appeared in: HPSSC - 2015

Explanation

Fetal hypoxia is assessed through a combination of screening and confirmatory tests.
Fetal heart monitoring (CTG) is the primary non-invasive screening method to detect patterns suggestive of hypoxia, such as late decelerations or reduced variability.
Fetal scalp blood sampling is an invasive procedure used to confirm fetal acidosis (a direct consequence of significant hypoxia) when CTG findings are non-reassuring.
Since both methods are integral to the assessment pathway for fetal hypoxia, the option including both is the most complete and correct answer.

Option A: Alpha-fetoprotein (AFP) is a biomarker used in prenatal screening for genetic disorders and neural tube defects, not for assessing acute fetal oxygenation status during labor.
Option B: This option is only partially correct. While fetal heart monitoring is a key component of assessing for hypoxia, it is primarily a screening tool. It does not represent the complete assessment process, which may include confirmatory tests.
Option C: This option is only partially correct. Scalp blood sampling is a specific, invasive test to confirm acidosis, but it is not the initial or sole method of assessment. It is typically performed only after non-reassuring findings on fetal heart monitoring.

Clinical Relevance

Nursing practice connection: This is primarily an exam-oriented knowledge point with limited direct bedside application, so retain Methods for Assessing Fetal Hypoxia as background academic context rather than a clinical decision trigger.
Recognizing non-reassuring fetal heart rate patterns is a critical nursing skill in labor and delivery. Prompt initiation of intrauterine resuscitation measures can improve fetal oxygenation and prevent adverse outcomes.
Nurses play a key role in communicating findings to the provider, preparing equipment for further testing like scalp sampling, and readying the team for a potential emergency delivery.
Patient safety is paramount. Understanding the indications and contraindications for scalp sampling (e.g., maternal HIV, hepatitis, active herpes, or fetal bleeding disorders) is essential.

How to Approach the Question

First, identify the core of the question: it asks for the methods used to assess 'fetal hypoxia'.
Evaluate Option A: Alpha-fetoprotein. Recall that AFP is a maternal serum screen for neural tube defects and is not related to intrapartum oxygen status. Eliminate this option.
Evaluate Option B: Fetal heart monitoring. Recall that this is the standard, continuous method of intrapartum surveillance to detect signs of fetal stress, which is often caused by hypoxia. This is a correct method.
Evaluate Option C: Scalp blood sampling. Recall that this is a more specific, invasive test used to confirm fetal acidosis when heart rate patterns are concerning. This is also a correct method.
Look at Option D: Both [B] and [C]. Since both fetal heart monitoring (for screening) and scalp blood sampling (for confirmation) are used in the clinical pathway to assess for fetal hypoxia, this option is the most comprehensive and accurate answer.

Concept Tested & Keywords

QucQnHfSEgTvWcy-MHbg-Q

E6 Obstetrics Williams pp. 45-64, 46-64

E6 Midwifery Obstetrics and Gynecology Nursing Sandeep Kaur p. 38-46